Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Chenai Mathabire (right), MSF nurse and Researcher won the HIV/TB Research Prize at this year’s IAS for her study on the feasibility of using Determine TB-LAM. Photograph by MSF
Feature story
Feature story |
27 July 2017
HIV/AIDS Tuberculosis

MSF nurse wins HIV-TB prize for life-saving TB test research

4 min
Gift mugs offered during the "accomplished MDR-TB treatment" graduation in the MSF Matsapha clinic. Matsapha, Manzini Region, Swaziland. Photograph by Alexis Huguet Photograph by Alexis Huguet
Feature story
Feature story |
15 June 2017
Tuberculosis
Eswatini

‘A long and gruelling seven years and now it is over’

4 min
Children queue at a vaccination point in the commune of Matoto, Conakry, Guinea. Médecins Sans Frontières/Doctors without Borders (MSF) is launching a large scale measles vaccination campaign in Conakry, the capital of Guina. Since the beginning of the year there have been 3468 confirmed cases and 14 deaths dues to measles in Guinea. Conakry and Nzérékoré are the most affected districts. Photograph by Markel Redondo Photograph by Markel Redondo
Feature story
Feature story |
20 April 2017
Vaccines
Guinea

Guinea – a respite against measles

3 min
MSF104231(High) Photograph by Vania Alves
Feature story
Feature story |
14 April 2017
Tropical & neglected diseases

On International Chagas Day, MSF asks the Bolivian government to increase the resources allocated to fight the disease

5 min
Children are vaccinated during the first day of a Measles vaccination programme in Conakry, the capital of Guinea. Photograph by Markel Redondo Photograph by Markel Redondo
Feature story
Feature story |
07 April 2017
Vaccines
Guinea

Guinea battling a large scale measles epidemic

An MSF team pays a home visit to Winile. She's 42, and has had an MDR-TB relapse. She was cured in 2014, after a 9-months treatment. She was diagnosed XDR-TB in Feb. 2016. Photograph by Alexis Huguet
Feature story
Feature story |
09 March 2017
Tuberculosis
Eswatini

Tuberculosis patients in Swaziland

Celumusa Hlatswako, an MSF mobile counselor, visits Winile, 39, XDR-TB patient & HIV-positive. They use sign language to communicate because Winile went deaf due to the side effects of the treatment. Matsapha airport, Manzini Region, Swaziland. Photograph by Alexis Huguet
Feature story
Feature story |
24 February 2017
Tuberculosis
Eswatini

Now I am better: a gruelling fight against TB

5 min
Tholakele (left), 39, MDR-TB patient, is talking to Yenziwe Malaza (right), MSF Psychosocial Supervisor from the Moneni project. National TB Hospital, Moneni, Manzini Region, Swaziland. Photograph by Alexis Huguet
Feature story
Feature story |
23 February 2017
Tuberculosis
Eswatini

New hope for patients with drug-resistant tuberculosis

6 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury